Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA seeking Administration and congressional viewpoints on interpretations of GATT legislation.

Executive Summary

FDA SEEKING ADMINISTRATION AND CONGRESSIONAL VIEWS ON GATT POLICY that the agency will adopt concerning generic approvals affected by the redefinition of patent terms mandated by the Uruguay Round Agreements Act. FDA's Office of Policy is circulating drafts of potential responses to a March 7 Glaxo citizen petition to members of Congress and the Clinton Administration for feedback on the agency's proposed policy.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel